Clinical TrailsHope for AFRS Sufferers: Dupixent’s Powerful Phase 3 Outcome Hope for AFRS Sufferers: Dupixent’s Powerful Phase 3 Outcome Read Post »
Clinical TrailsBayer’s Finerenone Significantly Reduces UACR in Adults with Chronic ... Bayer’s Finerenone Significantly Reduces UACR in Adults with Chronic ... Read Post »
Clinical TrailsFirst Oral PCSK9 Inhibitor from Merck Cuts LDL Cholesterol by 59% in HeFH P... First Oral PCSK9 Inhibitor from Merck Cuts LDL Cholesterol by 59% in HeFH P... Read Post »
Clinical TrailsRoche’s Fenebrutinib Achieves Groundbreaking Phase III Success as First O... Roche’s Fenebrutinib Achieves Groundbreaking Phase III Success as First O... Read Post »
Disease & Drugs Drugs Safety Alert ResearchFDA Revises Menopause Hormone Therapy Labels, Removing Black Box Safety War... FDA Revises Menopause Hormone Therapy Labels, Removing Black Box Safety War... Read Post »
Health Tidings ResearchNovo Nordisk and Emcure Join Forces to Expand Semaglutide Market in India w... Novo Nordisk and Emcure Join Forces to Expand Semaglutide Market in India w... Read Post »
Clinical TrailsAtacicept Achieves Breakthrough Phase 3 Results in Immunoglobulin A Nephrop... Atacicept Achieves Breakthrough Phase 3 Results in Immunoglobulin A Nephrop... Read Post »
New Drug ApprovalFDA Approves Linzess (Linaclotide) for Pediatric IBS-C: A Game Changer in T... FDA Approves Linzess (Linaclotide) for Pediatric IBS-C: A Game Changer in T... Read Post »
Clinical TrailsEli Lilly’s Eloralintide Phase 2 Trial shows up to 20% Weight Loss with P... Eli Lilly’s Eloralintide Phase 2 Trial shows up to 20% Weight Loss with P... Read Post »
Drugs Safety Alert ResearchFDA Crackdown: 18 Warning Letters Issued Over Illegal Marketing of Unapprov... FDA Crackdown: 18 Warning Letters Issued Over Illegal Marketing of Unapprov... Read Post »
Health TidingsFDA Rejects Biohaven’s Vyglxia for Spinocerebellar Ataxia Citing External... FDA Rejects Biohaven’s Vyglxia for Spinocerebellar Ataxia Citing External... Read Post »
Clinical TrailsRoche’s Gazyva Shows Breakthrough Phase III Results in Idiopathic Nephrot... Roche’s Gazyva Shows Breakthrough Phase III Results in Idiopathic Nephrot... Read Post »
New Drug ApprovalInnovative Brekiya® DHE Autoinjector Launched by Amneal for Rapid Relief o... Innovative Brekiya® DHE Autoinjector Launched by Amneal for Rapid Relief o... Read Post »
New Drug ApprovalKygevvi Brings Hope for Patients With Rare Mitochondrial Disorder Kygevvi Brings Hope for Patients With Rare Mitochondrial Disorder Read Post »
Clinical TrailsFDA Approves Rybelsus Oral Semaglutide for Cardiovascular Risk Reduction in... FDA Approves Rybelsus Oral Semaglutide for Cardiovascular Risk Reduction in... Read Post »
Lifestyle WellnessChamomile Extract for Better Sleep and Anxiety Reduction: What Research Sho... Chamomile Extract for Better Sleep and Anxiety Reduction: What Research Sho... Read Post »
Health TidingsDupixent® (Dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechno... Dupixent® (Dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechno... Read Post »
ResearchSemaglutide Users Report Major Reduction in “Food Noise” and Better Men... Semaglutide Users Report Major Reduction in “Food Noise” and Better Men... Read Post »
Clinical TrailsGefurulimab Symptom Relief in Myasthenia Gravis: PREVAIL Phase 3 Gefurulimab Symptom Relief in Myasthenia Gravis: PREVAIL Phase 3 Read Post »
Drugs Safety Alert ResearchFDA’s New Move to Protect Children from Unapproved Fluoride Drug Prod... FDA’s New Move to Protect Children from Unapproved Fluoride Drug Prod... Read Post »
Health TidingsYeztugo Wins Prestigious 2025 Prix Galien USA Award for Best Pharmaceutical... Yeztugo Wins Prestigious 2025 Prix Galien USA Award for Best Pharmaceutical... Read Post »
Policy & AcquisitionsPfizer vs. Novo Nordisk: The High-Stakes Battle for Metsera Pfizer vs. Novo Nordisk: The High-Stakes Battle for Metsera Read Post »
